Acrivon Therapeutics ACRV
NASDAQ ACRV
$2.10 +0.02 (+0.96%)
As of: Sep 30, 2026 · 9:57 AM EDT

Acrivon Therapeutics (ACRV) Total Liabilities (2021 - 2026)

Updated

Acrivon Therapeutics (ACRV) posted Total Liabilities of $12.43 million for Q2 2026, down 20.1% from $15.55 million a year earlier but up 0.9% from the prior quarter.

Analysis

Acrivon Therapeutics (ACRV) Total Liabilities (2021 - 2026) Analysis & Trends

At the end of FY2025, Acrivon Therapeutics' Total Liabilities came in at $17.2 million, down 13.1% from FY2024.

  • Annual Total Liabilities shows a four-year compound annual growth rate of -39.7% (FY2021 to FY2025).
  • In prior years, Acrivon Therapeutics' Total Liabilities was $19.8 million in FY2024 (+16.0%), $17.07 million in FY2023 (+58.8%), $10.75 million in FY2022 (-91.8%) and $130.4 million in FY2021.
  • Quarterly Total Liabilities has run from a low of $9.73 million in Q1 2023 to a high of $133.33 million in Q3 2022 over five years.
  • On a year-over-year basis, Total Liabilities has declined in each of the last four quarters, with growth averaging 3.2% over the last eight quarters.
  • The strongest year-over-year quarter for Total Liabilities in the past five years was Q4 2023, with growth of 58.8%; the weakest was Q4 2022, with a decline of 91.8%.
  • According to Business Quant data, Total Liabilities for the three prior quarters was $12.32 million (Q1 2026), $17.2 million (Q4 2025) and $16.7 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 116.09 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 141.05 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 87.82 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 80.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 65.46 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 83.95 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 37.53 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 115.64 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 7.18 Bn
10 Acrivon Therapeutics 88.27 Mn 88.27 Mn - 12.43 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.43 Mn
Mar 31, 2026 12.32 Mn
Dec 31, 2025 17.20 Mn
Sep 30, 2025 16.70 Mn
Jun 30, 2025 15.55 Mn
Mar 31, 2025 15.96 Mn
Dec 31, 2024 19.80 Mn
Sep 30, 2024 17.79 Mn
Jun 30, 2024 14.53 Mn
Mar 31, 2024 12.54 Mn
Dec 31, 2023 17.07 Mn
Sep 30, 2023 12.94 Mn
Jun 30, 2023 10.87 Mn
Mar 31, 2023 9.73 Mn
Dec 31, 2022 10.75 Mn
Sep 30, 2022 133.33 Mn
Dec 31, 2021 130.40 Mn
API Access

Acrivon Therapeutics Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=ACRV&period=max&api_key=YOUR_API_KEY